“Cannabidiol (CBD) is considered a non-psychoactive, antioxidant, and anti-inflammatory compound derived from the Cannabis sativa plant.
There are various reports on the versatile function of CBD, including ameliorating chronic inflammation and fibrosis formation in several tissue types.
This review focused on the anti-inflammation and anti-fibrotic effects of CBD based on modulating the associated chemokines/cytokines and receptor-mediated pathways.
This review thus recommends the continued study of CBD’s molecular mechanism in treating established and emerging inflammatory and fibrosis-related diseases.”
“In all, CBD shows immense promise as a possible treatment for chronic inflammation and the progression or development of fibrosis.”